# Exhibit Review — Gemini 3 Flash (Round 1)

**Role:** Visual exhibit advisor
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-03-02T16:04:09.791109
**Route:** Direct Google API + PDF
**Tokens:** 18917 in / 2172 out
**Response SHA256:** 9c36ddd650707f71

---

# Exhibit-by-Exhibit Review

## Main Text Exhibits

### Table 1: "Summary Statistics: Pre-Treatment Period (January 2018 – May 2021)"
**Page:** 10
- **Formatting:** Generally clean and follows standard economic style (booktabs). However, the "N states" and "N months" rows are strangely placed under Panel B even though they apply to the whole sample.
- **Clarity:** Good. The distinction between Terminators and Maintained Benefits is clear.
- **Storytelling:** Essential. It establishes the baseline differences (e.g., non-terminating states are much larger in terms of payments and beneficiaries).
- **Labeling:** Clear. 
- **Recommendation:** **REVISE**
  - Move "N states" and "N months" to a separate section at the bottom of the table (below Panel B) or include them in the general notes, as they are sample-wide descriptors.
  - Decimal-align the numbers in the "Mean" columns to improve readability.

### Figure 1: "Raw Trends: Mean HCBS Providers per State"
**Page:** 13
- **Formatting:** Professional "ggplot2" style. The dashed vertical line is helpful. 
- **Clarity:** The message is clear—divergence starts at the treatment line—but the seasonality (dips) makes the trend a bit noisy.
- **Storytelling:** High value. Shows the reader the raw data before moving to complex DiD estimators.
- **Labeling:** Y-axis is clearly labeled. Legend is well-positioned.
- **Recommendation:** **KEEP AS-IS**

### Figure 2: "Normalized Trends: HCBS Providers Relative to Pre-Treatment Mean"
**Page:** 14
- **Formatting:** Identical style to Figure 1.
- **Clarity:** Extremely clear. Normalizing to 100% (the 1.0 line) makes the parallel trends assumption much easier to verify visually.
- **Storytelling:** This is superior to Figure 1 for the paper's core argument. It highlights the 15-20% pandemic drop and the subsequent divergence.
- **Labeling:** Excellent.
- **Recommendation:** **KEEP AS-IS** (Consider moving Figure 1 to the Appendix to save space if needed, as Figure 2 is the "money shot" for identification).

### Table 2: "Effect of Early UI Termination on HCBS Provider Supply"
**Page:** 15
- **Formatting:** Professional. Standard errors in parentheses. Significance stars used.
- **Clarity:** Logical layout comparing the primary estimator (CS-DiD) with the traditional TWFE and a placebo.
- **Storytelling:** This is the core results table. Panel C is particularly effective at showing the "precise null" for the placebo group.
- **Labeling:** "ATT (CS)" and "Early Term x Post" are standard.
- **Recommendation:** **REVISE**
  - Add a row for "Pre-treatment Mean" for each outcome. This helps readers interpret the magnitude of the log-point coefficients (e.g., 0.0609) in the context of the raw levels.

### Figure 3: "Event Study: Effect of Early UI Termination on Active HCBS Providers"
**Page:** 16
- **Formatting:** Strong. The use of shaded confidence intervals is standard for AER/QJE.
- **Clarity:** The gradual "ramp up" is very visible.
- **Storytelling:** Supports Prediction 3 (gradual onset). 
- **Labeling:** "Months Relative to UI Termination" is correct.
- **Recommendation:** **KEEP AS-IS**

### Figure 4: "Event Studies: Multiple Outcomes"
**Page:** 17
- **Formatting:** 2x2 grid. Consistent scaling within panels.
- **Clarity:** A bit cluttered. The y-axis labels on the right-hand panels are missing or shared, making them slightly harder to read at a glance.
- **Storytelling:** Good for showing robustness across different margins (Claims, Payments, etc.).
- **Labeling:** Needs improvement on the shared axis.
- **Recommendation:** **REVISE**
  - Ensure each sub-panel has its own y-axis label or significantly increase the font size of the titles (Beneficiaries, Claims, etc.) to ensure no ambiguity.

### Figure 5: "HCBS vs. Behavioral Health Providers: Event Study Comparison"
**Page:** 18
- **Formatting:** Overlaid event studies.
- **Clarity:** High. The contrast between the red (HCBS) and blue (Placebo) is the strongest piece of evidence in the paper.
- **Storytelling:** Excellent. This should be a "Main Exhibit" in any presentation.
- **Labeling:** Legend is clear.
- **Recommendation:** **KEEP AS-IS**

### Table 3: "Robustness Checks: Effect on Log Active HCBS Providers"
**Page:** 19
- **Formatting:** A bit non-standard to mix p-values (for RI) and SEs in the same column.
- **Clarity:** Good summary of many different tests.
- **Storytelling:** Essential for a top-tier journal to show the result isn't driven by CA/NY or specific regions.
- **Labeling:** The "Notes" column is very helpful.
- **Recommendation:** **REVISE**
  - For the RI rows, place the p-value in the "Estimate" column and leave the "SE" column blank or put "N/A", rather than writing "p = 0.040" in the estimate box. It keeps the column types consistent.

### Table 4: "Triple-Difference: HCBS vs. Behavioral Health"
**Page:** 20
- **Formatting:** Standard.
- **Clarity:** Good.
- **Storytelling:** While the result is not significant (p=0.14), it’s important for the "reservation wage" narrative.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Figure 6: "Geographic Distribution of Early UI Termination"
**Page:** 21
- **Formatting:** Professional map.
- **Clarity:** The color ramp from red (early) to blue (late) is intuitive.
- **Storytelling:** Essential to show the regional clustering (South/Midwest) that justifies the within-region robustness checks.
- **Labeling:** Legend is clear.
- **Recommendation:** **KEEP AS-IS**

### Figure 7: "Randomization Inference: Distribution of Placebo Treatment Effects"
**Page:** 22
- **Formatting:** Standard RI histograms.
- **Clarity:** The red dashed line indicating the "Actual" effect is the industry standard.
- **Storytelling:** Proves the result isn't a fluke of the specific 26 states chosen.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

---

## Appendix Exhibits

### Table 5: "Early Termination of Federal Pandemic Unemployment Benefits"
**Page:** 31
- **Formatting:** Clean.
- **Clarity:** High.
- **Storytelling:** Necessary documentation of the treatment variable construction.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Figure 8: "Event Study: Effect on Total HCBS Claims"
**Page:** 33
- **Formatting:** Consistent with main text.
- **Clarity:** High.
- **Storytelling:** Supports the "Intensive Margin" discussion.
- **Labeling:** Clear.
- **Recommendation:** **KEEP AS-IS**

### Figure 9: "Placebo Event Study: Behavioral Health Providers"
**Page:** 34
- **Formatting:** Consistent.
- **Clarity:** High.
- **Storytelling:** Redundant with Figure 5 (which overlays this on the main result). 
- **Labeling:** Clear.
- **Recommendation:** **REMOVE** (Figure 5 already shows this data more effectively by providing a direct comparison. This standalone version adds little value).

---

## Overall Assessment

- **Exhibit count:** 4 main tables, 7 main figures, 1 appendix table, 2 appendix figures.
- **General quality:** The visual exhibits are exceptionally strong and "Journal Ready." They use modern DiD visualization techniques (CS-DiD, RI distributions) that reviewers at AEJ or AER expect to see.
- **Strongest exhibits:** Figure 2 (Normalized Trends) and Figure 5 (Placebo Comparison).
- **Weakest exhibits:** Figure 4 (Cluttered sub-panels) and Table 3 (Mixing p-values and coefficients in columns).
- **Missing exhibits:** 
    - **A Balance Table:** While Table 1 shows means, a formal balance table showing the *difference* in means with t-stats (or p-values) between terminators and non-terminators would be a standard addition for a DiD paper.
    - **A Robustness Plot:** A "coefficient plot" showing the ATT across 10-15 different specifications (varying controls, clusters, samples) in one vertical line would be more visually striking than Table 3.

**Top 3 improvements:**
1. **Consolidate/Refine Figure 4:** Either split the four event studies into two 1x2 figures or ensure each has a fully independent y-axis to prevent the "cluttered" feel.
2. **Add a Balance Table:** Formally test for pre-treatment differences in state characteristics (Unemployment rate, Medicaid expansion status, Republican vote share) to address the "Political Economy" section more rigorously.
3. **Table 2 Enhancement:** Add pre-treatment outcome means to the bottom of Table 2. Top journals want to see the "base" to judge if a 6% increase is coming from a small or large number.